home.aspx

 
.

JUST IN TIME RELEASE OF CAR-T CELL THERAPIES

November 11, 2019 | (10.00 am)
USA (United States of America)
Currently CAR T products typically represent the final treatment option for patients suffering from various forms of cancer. It is critical that CAR T products are manufactured and returned to the patient in an expedited manner. As such manufacturers of CAR T products must adopt and utilize Quality Risk Management (QRM) principles during manufacture, testing, and release.